MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Medinotec Inc.
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$5.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Medinotec's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Gregory Vizirgianakis | 4,750,179 | 40.40% | 13D (active) | Apr 16, 2025 |
| Stavros G. Vizirgianakis | 4,750,179 | 40.40% | 13D (active) | Apr 16, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gregory Vizirgianakis | President, Secretary, CEO, Director, 10% owner | 4,750,179 | 40.41% | Jun 12, 2025 |
| Niekerk Pieter Mohr van | CFO, Director | 401,965 | 3.42% | May 22, 2025 |
| Athanasios Spirakis | Director | 12,073 | 0.10% | Jun 17, 2025 |
| Stavros G. Vizirgianakis | Director, 10% owner | 4,750,179 | 40.41% | Jun 12, 2025 |
| Joseph P. Dwyer | Director | 0 | – | May 22, 2025 |